< Radiation Oncology < Esophagus

Esophageal Cancer: RTOG OPEN TRIALS
NumberTitle
04-36A Phase III Trial Evaluating The Addition Of Cetuximab To Paclitaxel, Cisplatin, And Radiation For Patients With Esophageal Cancer Who Are Treated Without Surgery


Esophageal Cancer: RTOG CLOSED TRIALS
NumberTitlePublication
02-46A Phase II Study Of A Paclitaxel-Based Chemoradiotherapy Regimen With Selective Surgical Salvage For Resectable Locoregionally Advanced Carcinoma Of The EsophagusASTRO Abstract
01-13Non-Operative Therapy Of Local-Regional Carcinoma Of The Esophagus: A Randomized Phase II Study Of Two Paclitaxel-Based Chemoradiotherapy RegimensPMID 18574157
97-16CALGB 9781: A Prospective Randomized Phase III Trial Comparing Trimodality Therapy (Cisplatin, 5-FU, Radiotherapy, And Surgery) To Surgery Alone For Esophageal CancerPMID 18309943
94-05A Phase III Intergroup Randomized Comparison Of Combined Modality Therapy For Carcinoma Of The Esophagus: High Dose Vs. Conventional Dose Radiation TherapyPMID 11870157
92-07A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagusPMID 10699886
90-12Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagusPMID 10078631
85-01Phase III trial of combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagusPMID 10235156
This article is issued from Wikibooks. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.